NASDAQ · Biotechnology

OCUL (OCUL) Stock

$8.50 -1.62% NASDAQ: OCUL Healthcare

Valuation

MetricValue
Price$8.50
Market Cap$1.86B
P/E Ratio-5.99
P/B Ratio3.02
P/S Ratio38.54
EPS (TTM)$-1.44
52-Week High$16.44
52-Week Low$6.23
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-68.55%
ROA-32.88%
ROCE-41.28%
Gross Margin-519.23%
Operating Margin-8.65%
Net Margin-5.58%
Debt/Equity0.14
Current Ratio14.81

Annual Financials (USD)

Metric20212022202320242025
Revenue$44.0M$51.0M$58.0M$64.0M$52.0M
Operating Profit$-78.0M$-79.0M$-82.0M$-172.0M$-270.0M
Net Profit$-7.0M$-71.0M$-81.0M$-194.0M$-266.0M
EPS$-0.98$-0.97$-1.02$-1.22$-1.42
Op Margin-179.3%-152.7%-141.0%-269.6%-521.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$205.0M$149.0M$252.0M$458.0M$808.0M
Total Liabilities$117.0M$114.0M$161.0M$143.0M$154.0M
Cash$164.0M$102.0M$196.0M$392.0M$737.0M
Borrowings$59.0M$64.0M$83.0M$76.0M$80.0M

Latest News

Ocular Therapeutix Eyes Q4 AXPAXLI NDA After FDA Alignment MarketBeat · Jul 23, 2026 3 Cash-Burning Stocks with Open Questions StockStory · Jul 21, 2026 Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 9, 2026 3 Small-Cap Stocks with Open Questions StockStory · Jul 8, 2026 Ocular Therapeutix™ to Participate in July Scientific and Investor Conferences GlobeNewswire · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-66.0M$-60.0M$-70.0M$-135.0M$-205.0M
Investing Cash Flow$-2.0M$-7.0M$-12.0M$-3.0M$-24.0M
Financing Cash Flow$2.0M$1.0M$-5.0M$-301.0M$0
Net Cash Flow$-64.0M$-62.0M$94.0M$196.0M$345.0M
Free Cash Flow$-67.0M$-63.0M$-76.0M$-136.0M$-217.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.24
EV / EBITDA-4.81
FCF Yield-10.82%
Quick Ratio14.49
Interest Coverage-22.50
Return 1Y-27.55%
Return 3Y94.28%
Return 5Y-29.84%

Ownership

Insiders Held0.94%
Institutions Held95.81%
Institutions Float Held96.71%
Institutional HolderSharesReport Date
FMR, LLC32,653,7642026-03-31
Deep Track Capital, Lp19,686,2822026-03-31
Blackrock Inc.16,132,9312026-03-31
Avoro Capital Advisors LLC12,315,0002026-03-31
Summer Road LLC11,879,8252026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
COGT $42.27 -1.33% -34.70 $7.22B 0.00%
EWTX $43.52 -2.03% -14.63 $4.68B 0.00%
GLPGGalapagos N.V. $27.98 +1.71% 3.57 $1.84B 0.00%
GPCRStructure Therapeutics Inc. $53.36 -3.23% -20.21 $3.07B 0.00%
IBRXImmunityBio, Inc. $7.00 -1.48% -8.32 $7.33B 0.00%

About OCUL

OCUL stock trades at $8.50 with a market capitalization of $1.86B. The stock is valued at a price-to-earnings (P/E) ratio of -5.99, price-to-book of 3.02, price-to-sales of 38.54. Over the past 52 weeks the stock has ranged between $6.23 and $16.44, and currently trades 48.3% below its 52-week high.

On profitability, OCUL generates a return on equity (ROE) of -68.55%, return on capital employed of -41.28%, an operating margin of -8.65%, a net profit margin of -5.58%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides